image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 21.02
-2.91 %
$ 975 M
Market Cap
-16.29
P/E
CASH FLOW STATEMENT
-12.5 M OPERATING CASH FLOW
-47.23%
17.8 M INVESTING CASH FLOW
130.69%
10.6 M FINANCING CASH FLOW
-35.09%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis BioLife Solutions, Inc.
image
Net Income -66.4 M
Depreciation & Amortization 12.3 M
Capital Expenditures -6.38 M
Stock-Based Compensation 31.7 M
Change in Working Capital 1.47 M
Others 11.7 M
Free Cash Flow -18.9 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Jan-2015 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Jun-1996 Jun-1995 Jun-1994 Jun-1993 Jun-1992 Jun-1991 Jun-1990
OPERATING CASH FLOW
Net Income (66.4) (139.8) (7.6) 2.7 (1.7) 3.3 (2.5) (8.0) (5.0) (3.3) (1.1) (1.7) (2.0) (2.0) (2.8) (2.8) (2.9) (1.1) (0.6) (0.7) (1.3) 0.2 (4.4) (2.8) (1.2) (1.3) (1.6) (3.4) (2.2) (2.6) (6.6) (4.7) (2.6) (1.7)
Depreciation & Amortization 12.3 16.5 12.9 5.1 1.8 0.3 0.3 0.4 0.3 0.3 0.2 0.2 97.1 K 71.7 K 93.7 K 29.3 K 61.6 K 49.8 K 66.1 K 0.2 0.3 0.2 0.3 0.3 0.3 0.3 0.4 0.4 0.4 (0.3) 100 K (0.3) (0.2) (0.2)
Deferred Income Tax 62 K (5.2) (20.1) (3.3) (1.5) 0.7 1.0 2.8 90.1 K 93.6 K 0 368 0 0 3.74 K 0 (117.9) (218.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Based Compensation 31.7 25.3 14.0 6.0 3.0 1.5 1.3 0.8 0.5 0.2 0.2 0.2 0.2 0.2 0.1 71.5 K 117.9 218.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 8.6 109.7 (0.4) (2.1) 4.0 (0.1) 0.2 0.3 (0.1) 0.2 0.1 0.9 76 K 1.63 K 782 43.8 K 0.1 0.3 41.7 K 0 1.6 (2.9) 37.5 K 36.2 K (0.7) 0.2 0.4 (0.1) 0.5 0.9 0.4 0.3 0.4 0.4
Change in Working Capital 1.5 (14.9) (3.5) (1.8) (4.5) (3.3) 0.3 (0.5) (0.8) (0.6) 0.6 1.2 0.6 0.5 0.1 0.5 44 K 0.1 64.8 K 1.1 (1.4) (0.1) 1.4 (0.4) 1.3 0.8 (0.7) 1.1 (0.3) (0.6) (2.1) 0.4 100 K 0.2
Cash From Operations (12.5) (8.5) (4.8) 6.5 1.2 2.3 0.6 (4.3) (5.0) (3.2) 0.1 0.9 (1.0) (1.3) (2.4) (2.1) (2.7) (0.7) (0.6) 0.5 (0.9) (2.7) (2.6) (2.9) (0.3) 29.1 K (1.5) (2.1) (1.5) (2.6) (8.4) (4.3) (2.5) (1.3)
INVESTING CASH FLOW
Capital Expenditures (6.4) (10.4) (8.4) (4.6) (0.7) (0.5) (0.1) (1.3) (1.4) (0.6) (0.2) (1.2) 93.5 K 28.4 K (0.4) 46.7 K (0.1) 35.6 K 15.1 K 65.8 K 11.2 K 87.4 K (0.3) (0.2) 0 (0.2) (0.4) 60.4 K (0.3) (0.2) (0.9) (0.4) 100 K 0
Other Items 24.2 (47.7) (4.3) (19.1) (26.3) (6.0) 233 1.7 5.7 (7.5) 0 1.4 K 2.1 K 0 0 0 0 0 18.9 K 0 0 2.2 0 15 K (0.4) 44.9 K 0.1 4.76 K 2.89 K 1.0 8.9 (9.4) 0.9 (1.1)
Cash From Investing Activities 17.8 (58.1) (12.6) (23.7) (27.0) (6.5) (0.1) 0.4 4.2 (8.1) (0.2) (1.2) 91.4 K 28.4 K (0.4) 46.7 K (0.1) 35.6 K 3.82 K 65.8 K 11.2 K 2.1 (0.3) (0.2) (0.4) (0.2) (0.2) 65.2 K (0.3) 0.8 8.0 (9.8) 0.8 (1.1)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 (4.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (1.1)
Total Debt Repaid (0.5) 17.8 (2.9) 1.0 0 0 1.0 3.0 0 0 0 0.5 1.1 1.1 2.8 2.2 2.6 28.4 K 0.2 (0.7) 0.4 0.3 10.9 K 35.7 K 40.8 K 52.8 K 38.7 K 0 0 14.1 K 0 0 0 0
Dividends Paid 0 0 0 0 0 (0.4) (0.1) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.8 (1.5) 0.1 1.0 1.6 8.6 3.9 0.2 0.4 83.6 K 50.5 K 0 0 0 2.6 K 2.33 K 0.2 (0.2) 0 0 0 0 0 (0.1) 0 0.2 56.2 K 2.3 (1.4) 2.2 100 K 100 K 4.6 4.3
Cash From Financing Activities 10.6 16.3 (2.8) 101.2 1.6 28.1 4.8 3.2 0.4 13.7 50.5 K 0.5 1.1 1.1 2.8 2.2 2.8 0.7 0.2 (0.7) 1.6 0.3 1.1 5.2 0.5 0.2 94.8 K 2.3 0.6 2.3 100 K 11.1 4.6 4.3
CHANGE IN CASH
Net Change In Cash 16.0 (50.4) (20.6) 84.0 (24.2) 24.0 5.3 (0.8) (0.4) 2.4 40.2 K 0.2 13.7 K (0.1) 40.4 K 42.2 K 62.2 K 66.4 K (0.3) (0.3) 0.7 (0.2) (1.9) 2.1 (0.1) 11.2 K (1.6) 0.1 (1.3) 0.5 (0.3) (3.0) 2.9 1.9
FREE CASH FLOW
Free Cash Flow (18.9) (18.9) (13.2) 1.9 0.5 1.8 0.5 (5.6) (6.4) (3.8) 90.7 K (0.3) (1.1) (1.3) (2.8) (2.2) (2.8) (0.7) (0.6) 0.4 (0.9) (2.8) (2.9) (3.1) (0.3) (0.2) (1.9) (2.1) (1.9) (2.8) (9.3) (4.7) (2.6) (1.3)